Introduction
Chronic Obstructive Pulmonary Disease (COPD) has a great medical and social impact on public health in Italy as at least 10% of general population is affected by COPD [1] ; more than 15% of these subjects is suffering from severe COPD [2] , and they presumably are living in disabled conditions.
Pulmonary Rehabilitation (Rehab) is a consolidate interventional strategy that can contribute to control and alleviate symptoms; optimize functional capacity [3] ; recover lung function and quality of life as much as possible [4] , and reduce rehospitalisation due to exacerbations [5] . Rehab also proved cost effective [6] . However, despite these favourable outcomes, the prevalence of COPD patient who attend Rehab centres or undergo any Rehab protocol is not known. No national data is available in Italy, but it is presumed that the vast majority of COPD patients are excluded from Rehab in our country. This would suggest the need for other feasible treatments which, in the absence of Rehab, could however surrogate some relevant Rehab's benefits to these patients to.
For the present study, it has basically been hypothesised that essential amino acid (EAA) supplementation could allow patients with COPD to achieve two strong rehab outcomes just at home, such as an improved physical activity and a better quality of life [3] . This hypothesis relies on the following considerations: firstly, EAAs, by promoting protein synthesis [7] , can increase body mass (mainly the muscle portion) which plays a crucial role for the exercise performance and the perception of well-being. Secondly, preliminary studies carried out by two independent groups [8, 9] have shown that EAA supplementation increases physical activity, cognition and quality of life in cachectic/sarcopenic COPD subjects, while another study found that EAAs can improve the nutritional state; the muscle metabolism, and the exercise capacity in individuals with chronic heart failure [10] . Furthermore, several studies found that EAAs work as precursors in the synthesis of brain neurotransmitters [11] which are involved in mood, behavioural motor activity, and cognition [12] .
Therefore the effects of EAAs on physical performance and quality of life of sarcopenic patients with severe COPD living at home were investigated.
Methods

Patients
Eighty-eight outpatients with stable, severe COPD (GOLD class 3-4) were selected from those regularly attending our Units and enrolled according to a randomised, double-blind, parallel groups design.
Patients were selected on the basis of the following criteria: 1. never admitted to any Rehab programme; 2. daily energy ≥28 Kcal/Kg, and protein intake ≥1 g/Kg; 3. age >40 yrs, and body weight stable ± 1 Kg over the last six months; 4. body mass index (BMI) <23 Kg/m 2 ; 5. baseline post-bronchodilator FEV 1 (forced expiratory volume in 1 sec) <50% predicted; 6. FEV 1 reversibility <12% from baseline after salbutamol 400 mcg; 7. FEV 1 /FVC (forced vital capacity) <70%.
Exclusion criteria were: age <40 yrs; postbronchodilator FEV 1 >50% predicted; FEV 1 /FVC >70%; FEV 1 reversibility >12% from baseline after salbutamol 400 mcg; BMI >23 Kg/m 2 ; any mental deterioration severely affecting the adherence to protocol procedures and treatment assumption; the occurrence of acute exacerbation of COPD in the last four weeks; diabetes; heart failure; endocrine disorders, and neoplasms.Patients were regularly assuming respiratory drugs since long time (Long-acting antimuscarinic -LAMA; long-acting β 2 adrenergics -LABA, inhaled corticosteroids -ICS).
All participants were fully informed about the nature of the study and gave their written consent, with approval of local technical ethics committee.
The supplementation protocol
An oral mixture of essential amino acid (EAAs) (table 1) was the active treatment, while the control treatment was an isocaloric placebo.
Subjects were randomised to receive 4 g of EAAs bid (n=44) or an undistinguishable dose of placebo (n=44) at 10:00 am and 5:00 pm, for 12-week. The oral EAAs mixture (Aminotrofic) was manufactured by Professional Dietetics, Milan, Italy. Investigators were blinded to the randomisation table, the code assignments, and the procedure. As subjects were enrolled, they were assigned a progressive number.
Safety was also checked during the study by monitoring the occurrence of serious side effects (i.e., gastrointestinal symptoms, such as abdominal pain; nausea, or diarrhoea).
The use of respiratory drugs was comparable in the two groups, and LAMA was equally prevailing in both groups (68.2 and 70.4%, respectively).
One week before, and after 4 and 12 weeks of the protocol patients underwent the following procedures, after overnight fasting, at 8-10 am: 1. the physical activity: the daily ambulation during the patients' free time at home was measured by using the Sense Wear Armband Pro3 (Body Media; Pittsburgh, PA, USA) placed on the upper right arm of each patient and continuously worn for one week. Armbands consented to estimate the energy expenditure (Kcal) during the daily life by using an accelerometer, together to non-invasive physiological measures [13] . The numbers of steps performed over one week were divided by seven to obtain the average number of steps daily walked and the corresponding energy expenditure; 2. the health status: the St George's Respiratory Questionnaire (SGRQ) was chosen to measure the disease-specific health status because it is reproducible and specific for respiratory patients. Briefly, the SGRQ investigates three main domains including symptoms (distress from respiratory symptoms); activity and impact on daily life and wellbeing. We calculated the sum of the single partial scores in order to obtain a total score up to 100 points; higher the score, higher the impairment of the patient's health status. As both the physical performance and the quality of life, which are mutually interdependent, depend on several factors including the body composition [14, 15] ; the nutritional intake, the muscle strength and metabolism; the arterial blood gas tensions, saturation of oxygen and the cognitive status, also the following variables were measured:
• the body weight and height, and the body mass index (BMI) (Kg/m 2 ) was calculated; • the body composition was measured by means of single-frequency bio-impedance analysis (BIA; 50 Hz; TANITA BC-420 MA; TANITA CORP, Tokyo Japan) with participants in a supine position. The fat-free mass (FFM) was calculated by using the COPD-specific equation, while the fat mass (FM) was calculated as the difference between the total body weight and the FFM. BIA was extensively validated in patients with COPD. BIA measurements were performed by the same trained authors. FFM and FM were expressed in Kg and as Kg/height-squared (FFMI) [16] , i.e. lean body mass index (LBMI). FFMI <16 Kg/m 2 in men and FFMI <15 Kg/m 2 in women were assumed as indicators of a low FFMI [17] and sarcopenia; • the nutritional intake was measured by means of a 3-day food diary [18] . Each patient was asked to keep a food diary at home for 3 consecutive days to fill before and after meals in order to register both the kind and the weight of cooked or uncooked food assumed. We converted this data to raw equivalents by using appropriate table when necessary [19] .
Patients became accustomed to keeping a nutritional diary as an essential part of their clinical control over time. Moreover, patients were regularly reminded of the importance of keeping an accurate diary for this study. The principal investigator was responsible for keeping the patients informed; for checking the food diaries, and for calculating nutritional intakes (via a computerized system set up by our group) [20] . Energy (Kcal) and macronutrient intake (carbohydrates, proteins, and lipid expressed in g) were also related to the patient' body weight (Kg); • the muscle strength: this function was measured by means of an hydraulic hand dynamometer Jamar (Sammons Preston Rolyan, Bolingbrook, Canada) as it measures quantitatively the muscle function in different joints [21] . Both hands were tested three times, and the best results for each hand was used for comparing the effect of treatments. All measurement were performed in the morning (between 8:00-10:00 am), in the sitting position, and with the arm held in a comfortable position as described by Spijkerman et al. [22] ; • the muscle metabolism: lactate plasma concentration of [23] (µmol/l) was measured in all patients in peripheral venous blood samples, its increase mirroring the enhancement of the muscle anaerobic pathway, such as a reduced activity of the aerobic cycle for energy formation; • the cognitive function: patients' cognition was measured by means of the Mini Mental State Examination (MMSE) [24] ; the range of the score is 0 (maximal cognitive dysfunction) -30 (optimal cognitive function), while a score >24 denotes a normal cognitive function; • blood gas tensions: arterial oxygen (PaO 2 , mmHg) and carbondioxide (PaCO 2 , mmHg) partial pressures were measured (ABL 735 analyser, Radiometer, Copenhagen, DK) in blood samples drawn anaerobically from the left radial artery.
Statistics
Descriptive statistics (mean ± standard deviation) were calculated for all variables. The unpaired Student's t test was used for comparing basic data of the EAA supplemented group vs those with placebo. The analysis of variance for repeated measures was used to evaluate the trends for all variables over time. Statistical significance was expressed as the value of the time group interaction, testing the various trends between patient belonging to the placebo or to the EAA group. A significance level of p<0.05 was accepted.
Results
Baseline characteristics
The two groups of patients were comparable in terms of body weight; body composition; lung function; muscle metabolism; physical activity; level of cognitive dysfunction, and perception of their health status (table 2) . Nutritional intake (table 3) ; muscle strength, and energy expenditure for ambulation (table 4) were also similar in the two groups.
According to the inclusion criteria, all patients were sarcopenic (LBMI <16 Kg/m 2 in men, <15 Kg/m 2 in women).
Patients had a reduced muscle strength together an increased anaerobic metabolic pattern as indicated by the elevated levels of plasma lactate which corresponds to ≥8-fold the average limit of normal values. Liver capacity for protein synthesis was significantly lowered, thus leading to mild hypoalbuminemia.
An important reduction of physical activity was also found. The patients' walking capacity was slightly higher than 600 steps/day. It was calculated that the energy expenditure normalized for FFM was similar in the two groups (1.27 ± 0.59 Kcal/Kg FFM in placebo patients vs 1.3 ± 0.75 in treated ones) during ambulation. Finally, patients showed an altered cognition and a poor perception of their health status and quality of life.
In other words, in basal conditions, severe COPD patients recruited were in stable condition and sarcopenic; had an equivalent nutritional intake, and were characterized by an impaired muscle strength; an increased anaerobic metabolism; a substantial reduction of their daily physical; cognitive performances, and quality of life.
Variables at three months
After 12 weeks of treatment, only patients EAAs supplemented, but not those assuming placebo, improved significantly their body weight (+5.53 ± 3.47 Kg; p=0.001); LBMI (+1.34 Kg/m 2 ± 0.29; p=0.06): muscle strength (+1.6 Kg ± 0.24; p=0.05); saturation of oxygen (+4.75 mmHg ± 2.61; p=0.03); physical activity (+502 steps, +56%; p=0.02); serum total protein concentration (p=0.05); cognitive dysfunction (p=0.02), and quality of life (p<0.01).
Moreover, significant differences between the two groups were also proved in terms of body weight (p=0.005); FFM (p=0.04); muscle strength (p<0.01); saturation of oxygen (p=0.05); serum albumin (p<0.001); cognitive function (p=0.02); quality of life (p<0.001); physical performance (p=0.003), and energy expenditure for ambulation (p<0.001) (table 4).
Discussion
Data from the present study indicates that sarcopenic, severe COPD subjects can obtain even at home some substantial rehab outcomes (i.e the improvement in their physical activity and quality of life) if supplemented uniquely with EAAs.
Though physical activity and quality of life are strictly linked [25] and mutually affecting each other [25] , EAAs may separately affect each of them. 
a) EAAs and physical activity
The patients enrolled in the present study originally had a very sedentary life style [26] . The improvement in daily physical activity following EAA supplementation was likely due to a substrate-associated improvement of body weight and composition [14, 15, 27] ; muscle strength; muscle energy metabolism; muscle and systemic acidosis, and saturation of oxygen.
The gain in body weight, and mainly in FFM, was probably due to EAA stimulation of muscle protein synthesis. This overall metabolic orientation is also suggested by the increased serum albumin level which mirrors the enhanced protein synthesis occurring in the liver. Both the increased body weight/FFM and albumin synthesis cannot be referred to a better dietary intake because the latter did not change over time and was quite similar in the two groups.
Since low oxygen tensions stimulate the production of tumour necrosis factor [28, 29] which affects (such as reduces) albumin synthesis, an improved oxygen tension can likely contribute to increase body weight/composition and albumin, even though data of the present study does not provide any definitive explanation of the improved saturation of oxygen. It is also presumable that an ameliorated cardiac performance associated with EAAs supplementation [30] could improve the blood distribution throughout the different pulmonary regions.The mechanisms by which EAAs stimulate the FFM growth are both direct and indirect. Direct, because EAAs stimulate the protein synthesis [31] and inhibit proteolysis at the same time [32] . Indirect, because EAAs boost protein formation by inducing protein production, and also increase the biological activity of insulin-like growth factor (IGF-I) [33] . The documented evidence that a three-month supplementation of 7.5 g/day of EAAs in older women increases base IGF-I expression [34] supports this hypothesis.
The independence of EAAs activity from insulin [35] is particularly valuable for those COPD patients who are insulin resistant or have reduced their levels of circulating anabolic hormones [36] .
Changes in body composition observed in the present study following EAAs vary quantitatively and qualitatively from previous researches. Actually, the observed increase in body weight (+5.53 Kg) and in FFM (+3.66 Kg) following EAAs proved higher than those obtained in COPD patients after an 8-week program consisting of nutritional supplementation combined with intensive Rehab [37] . While changes in body composition mainly consisted of increased FFM with EAAs, megestrol administration mainly induced a FAT mass increase [38] . Moreover, the tissue increase was not due to a higher nitrogen intake from EAAs because total (diet + supplementation) nitrogen intake [10 g ) in treated subjects was equal to that of patients assuming placebo.
The muscle strength is a major determinant of physical activity; so, the improved physical performance in the EAAs group was also due to improved muscle strength.
The significant reduction in basal hyperlactatemia after EAAs treatment [28, 29, [39] [40] [41] [42] is another important factor further contributing to a better exercise tolerance for at least three reasons. First, the diminution of blood hydrogenions reduces the excess of ventilation particularly during the physical effort. Secondly, reduced lactate formation suggests increased efficiency and efficacy of aerobic production; this is also supported by the high improvement in energy developed during daily physical activity, and normalized for lean body mass in EAAs supplemented patients. Interestingly, the opposite occurred in subjects assuming placebo in which muscle energy expenditure worsened over time. Third, a diminished cellular acidosis lowers the rate of both somatic and myofibrillar proteolysis [43] otherwise primed by a low intracellular pH. The biochemical mechanisms by which EAAs lead to a better balance between the anaerobic and the aerobic muscle metabolism are based on the evidence that these can be used directly in aerobic cycles as fuel alternative to glucose [44] and, indirectly, because they shift the lactate pyruvate reaction towards the pyruvate formation [44] . This mechanism is relevant to COPD patients because it also allows them to partially overcome the block of glucose aerobic oxidation from high levels of pro-inflammatory cytokines [39] .
Interestingly, EAAs-induced changes in muscle-liver metabolism anticipate the changes in body composition, thus suggesting that these rely on improved muscle-liver axisis. In other words, the limited lactate processing spares energy which becomes more available for protein synthesis.
b) EAAs and quality of life
Patients assuming EAAs also improved the subjective perception of their own health status. It is important to note that this was achieved at home, such as excluding any effect due to a better care delivered in specifically organised settings [45] .
In addition the optimisation of quality of life may be due to an improved nutritional status [46, 47] and muscle strength [25] ; whole body anabolic process; higher saturation of oxygen; increased physical activity of daily living [25] , and reduced cognitive dysfunction [25] . Despite the high prevalence in COPD subjects [48, 49] , cognitive dysfunction is often underestimated in clinical practice, and an altered cognition may reflect the pulmonary dysfunction [48] and/or hyposaturation of oxygen [50, 51] . The improvement of saturation of oxygen can contribute to reduce cognitive dysfunction [8] , while EAAs may directly influence cognition as several amino acids are precursors of brain neurotransmitters [8] .
Due to a better perception of their own health status, patients can have a better adherence to pharmacological treatments which can contribute to symptom control or minimisation [52] , and a possible reduction of hospitalisations [26] .
In conclusion, data from the present study shows that the simple supplementation of essentials amino acids to severe sarcopenic COPD patients living at home and not admitted to any rehab program may improve both their physical autonomy and quality of life, thus surrogating the effect of a Rehab course.
From a clinical perspective, this study confirms data obtained in previous investigations carried out in patients with COPD [8, 9] or with chronic heart failure [10] who were supplemented with the same amino acid formula, at the same dose used in the present study. EAAs should not be intended as a substitute for Rehab whenever possible. EAAs may rather be used in those patients who, for any reason, cannot undergo Rehab or do not tolerate any intensive physical training due to their severe co-morbidities or frailty. In patients with more severe forms of COPD, EAAs may induce better nutritional-metabolic conditions allowing patients to initiate a program of exercise training.
Further research is needed to assess whether or not EAAs supplemented to subjects on Rehab could enhance programme effects and/or keep them at home for longer [3] .
The present study has several limitations. The patients' physical performance was not documented by standardised methods (i.e. exercising on a treadmill or on a stationary bicycle) that would have allowed us to quantify both the power and the work load, and to analyse at the same time oxygen consumption and carbon dioxide concentration in expiratory flow. This information would have allowed us to better understand the mechanisms for the gain in physical performance.
Measurements of blood lactic acid during and/or after exercise would have highlighted muscle metabolic changes associated with EAAs. Small differences in body/muscle nutritionalmetabolic changes were not analyzed because of the limited sample size. Moreover, patients were not investigated after the end of the protocol, so we were not able to assess the persistence of EAAs effects. Further specific researches are needed in order to focusing these aspects.
